从寡类细胞的角度识别阿尔茨海默病:现象还是病变?
Jingji Wang1,2, Yilan Zhen1, Jun Yang1,3
1Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, and Key Laboratory of Molecular Biology (Brain Diseases), Anhui University of Chinese Medicine, Hefei, China.
CNS neuroscience & therapeutics
|March 22, 2024
概括
寡细胞 (OL) 功能障碍是阿尔茨海默病 (AD) 发病的一个关键因素. 针对OLs提供了早期诊断和AD的新疗法策略的潜力.
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生物化学
背景情况:
- 阿尔茨海默氏病 (AD) 的特征是粉样β,高酸化和微质激活.
- 氧基细胞 (OLs) 越来越多地被认为在AD病原和治疗中的作用.
研究的目的:
- 更新OL分化和成熟的监管目标.
- 强调OLs在AD发生和治疗中的关键作用.
主要方法:
- 审查了规范OL分化和成熟的目标.
- 对AD中的OL的临床和基础研究分析.
- 诊断和治疗应用的讨论.
主要成果:
- 调节OLs (转录因子,胆固醇调节剂,微RNAs) 的分子与AD有关.
- 临床数据显示,阿尔茨海默病患者的OL功能受损.
- 基础研究证实了OL在AD病理学中的中心作用.
- 现有的药物在AD模型中显示了OL修复的潜力.
结论:
- 寡细胞功能障碍是AD病变发生的一个重要因素.
- 调节OLs的因素可以作为早期诊断生物标志物.
- 刺激OLs为开发抗AD药物提供了一个有希望的途径.
相关概念视频
Alzheimer's Disease: Overview
469
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
469
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Parkinson's Disease: Overview
541
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
541
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
610
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
610
Neurogenesis and Regeneration of Nervous Tissue
770
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
770


